FHIR IG analytics83,706 resources
By Version
By Authority
By Realm
Start Prev Rows 45000 - 45200 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.30.json | Prediabetes HbA1c Tests | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.31.json | Prediabetes HbA1c Tests | active | 2023-01 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.32.json | Prediabetes HbA1c Tests | active | 2023-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.33.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.34.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.35.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.36.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.37.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.38.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.4.json | Glycemic Screening Tests | active | 2025-03 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.40.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.41.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.42.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.43.json | Analgesics for Acute Pain | active | 2025-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.49.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.5.json | Glycemic Screening Tests | active | 2023-01 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.52.json | Remote Physiologic Blood Pressure Monitoring | active | 2024-10 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.57.json | Aldosterone Receptor Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.58.json | Alpha Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.59.json | Angiotensin Converting Enzyme Inhibitor for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.6.json | Glycemic Screening Tests | active | 2023-01 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.60.json | Angiotensin II Receptor Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.61.json | Beta Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.62.json | Calcium Channel Blocker Dihydropyridine for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.63.json | Calcium Channel Blocker Non Dihydropyridine for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.64.json | Central Acting for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.65.json | Direct Renin Inhibitor for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.66.json | Loop Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.67.json | Neuronal Blocking Agent for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.68.json | Potassium Sparing Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.69.json | Thiazide Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.7.json | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.70.json | Vasodilator for Hypertension | active | 2024-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.73.json | Analgesics for Acute Pain (Non Parenteral Route) | active | 2025-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.74.json | Analgesics for Acute Pain (Parenteral Route) | active | 2025-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.75.json | Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes | active | 2024-11 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.77.json | Antihypertensive Medication Classes | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.78.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.79.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.8.json | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.84.json | Renal Colic | active | 2025-04 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.85.json | Renal Colic | active | 2025-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.86.json | Renal Colic | active | 2025-04 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.88.json | Direct LDL Cholesterol | active | 2025-05 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.89.json | Calculated LDL Cholesterol | active | 2025-05 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.9.json | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.50.json | Urinary retention | active | 2017-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.51.json | Urinary retention | active | 2017-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.52.json | Urinary retention | active | 2017-06 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.65.json | Morbid Obesity | active | 2018-04 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.66.json | Morbid Obesity | active | 2018-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.67.json | Morbid Obesity | active | 2018-04 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.68.json | BMI greater than 40 | active | 2019-02 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.69.json | Morbid Obesity | active | 2019-02 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.141.json | Contraceptive Patch SNOMED Devices | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.143.json | Live Birth Delivery CPT Procedures | active | 2024-09 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.144.json | Contraceptive Patch SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.145.json | Contraceptive Patch SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.146.json | Contraceptive Patch ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.147.json | Contraceptive Patch ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.148.json | Live Birth Delivery ICD10PCS Procedures | active | 2024-09 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.149.json | Contraceptive Patch HCPCS Devices | active | 2021-10 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.15.json | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests | active | 2025-03 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.150.json | Contraceptive Patch LOINC | active | 2021-10 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.152.json | Live Birth Delivery Procedures SNOMED CT | active | 2024-09 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.153.json | Contraceptive Ring SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.154.json | Contraceptive Ring SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.155.json | Contraceptive Ring SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.156.json | Contraceptive Ring ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.157.json | Contraceptive Ring ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.159.json | Contraceptive Ring HCPCS Devices | active | 2022-01 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.160.json | Contraceptive Ring LOINC | active | 2021-10 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.161.json | Contraceptive Implant SNOMED Devices | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.162.json | Contraceptive Implant ICD10PCS Provision Procedures | active | 2021-10 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.163.json | Contraceptive Implant SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.164.json | Contraceptive Implant SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.170.json | Contraceptive Implant ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.171.json | Contraceptive Implant ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.173.json | Contraceptive Implant HCPCS Devices | active | 2021-10 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.174.json | Contraceptive Patch Devices | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.177.json | Live Birth Delivery Procedures | active | 2024-09 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.178.json | Contraceptive Ring Surveillance | active | 2021-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.180.json | Contraceptive Implant CPT Provision Procedures | active | 2021-10 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.181.json | Injectable Contraceptive SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.182.json | Injectable Contraceptive SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.183.json | Injectable Contraceptive SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.185.json | Injectable Contraceptive ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.186.json | Injectable Contraceptive ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.187.json | Injectable Contraceptive HCPCS Provision Procedures | active | 2021-10 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.188.json | Injectable Contraceptive LOINC | active | 2021-10 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.189.json | Oral Contraceptive Pill SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.190.json | Oral Contraceptive Pill SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.191.json | Oral Contraceptive Pill SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.193.json | Oral Contraceptive Pill ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.194.json | Oral Contraceptive Pill ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.195.json | Oral Contraceptive Pill HCPCS Provision Procedures | active | 2021-10 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.196.json | Oral Contraceptive Pill LOINC | active | 2021-10 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.197.json | Injectable Contraceptive Provision Procedures | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.198.json | Injectable Contraceptive Surveillance | active | 2021-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.199.json | Oral Contraceptive Pill Provision Procedures | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.200.json | Oral Contraceptive Pill Surveillance | active | 2021-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.201.json | Contraceptive Implant Devices | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.202.json | Contraceptive Implant Provision Procedures | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.203.json | Contraceptive Implant Surveillance | active | 2021-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.96.json | Infecund Not for Contraceptive Reasons SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.10.json | ASN Screening Declined | active | 2024-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.2.json | Intracranial or Intraspinal surgery | active | 2022-02 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.22.json | Emergency Department Observation | active | 2024-09 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.27.json | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.28.json | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.29.json | Bed Assigned | active | 2024-05 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.3.json | Malignant Intracranial Neoplasm Group | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.31.json | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.32.json | Healthcare Agent and Power of Attorney Documentation | active | 2024-09 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.33.json | Advance Directive Documentation | active | 2024-10 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.34.json | Advance Directive Documentation | active | 2024-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.35.json | Advance Directive Documentation | active | 2024-09 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.36.json | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.37.json | Portable Medical Order(s) Documentation | active | 2024-09 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.38.json | Advance Care Planning Discussion Documentation | active | 2024-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.4.json | Thrombolytic medications | active | 2021-10 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.40.json | Advance Care Planning Documentation | active | 2024-09 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.41.json | Advance Care Planning Documentation | active | 2024-09 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.42.json | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.43.json | Advance Directive Documentation | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.45.json | Advance Care Planning Documentation | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.46.json | Advance Care Planning Documentation | active | 2024-10 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.47.json | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.48.json | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.49.json | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.5.json | Allergy to thrombolytics | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.50.json | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.51.json | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.52.json | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.53.json | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.54.json | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.55.json | Intervention for Positive Homelessness Screen | active | 2024-11 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.56.json | Intervention for Positive Homelessness Screen | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.57.json | Non Invasive Oxygen Therapy Device Codes | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.58.json | Goals, preferences, and priorities for medical treatment | active | 2025-04 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.6.json | Thrombolytics Adverse Event | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.7.json | Intraspinal surgery | active | 2024-02 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1176.58.json | Food Insecurity Screening Positive | active | 2023-10 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.1.json | Ezetimibe Therapy | active | 2023-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.10.json | Antihypertensive Medications | active | 2024-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.100.json | Allergy or Intolerance to ACE Medication | active | 2024-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.101.json | Allergy or Intolerance to ARB Medication | active | 2024-11 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.102.json | Chronic Kidney Disease Stage 1 | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.103.json | Chronic Kidney Disease Stage 2 | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.104.json | Chronic Kidney Disease Stage 3 | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.105.json | Chronic Kidney Disease Stage 4 | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.106.json | Chronic Kidney Disease Stage 5 | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.107.json | ICD10 CM Chronic Kidney Disease Stage 1 | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.108.json | ICD10 CM Chronic Kidney Disease Stage 2 | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.111.json | AHA GWTG Chronic Kidney Disease Stage 2 | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.112.json | ICD10 CM Chronic Kidney Disease Stage 3 | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.113.json | ICD10 CM Chronic Kidney Disease Stage 4 | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.114.json | ICD10 CM Chronic Kidney Disease Stage 5 | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.115.json | AHA GWTG Chronic Kidney Disease Stage 1 | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.116.json | AHA GWTG Chronic Kidney Disease Stage 3 | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.117.json | AHA GWTG Chronic Kidney Disease Stage 4 | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.118.json | SNOMED CT Atrial Fibrillation | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.119.json | ICD10 CM Atrial Fibrillation | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.121.json | AHA GWTG Atrial Fibrillation | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.123.json | SNOMED CT Hyperlipidemia | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.124.json | ICD10 CM Hyperlipidemia | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.125.json | AHA GWTG Hyperlipidemia | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.126.json | SNOMED CT Hypertriglyceridemia | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.127.json | ICD10 CM Hypertriglyceridemia | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.129.json | AHA GWTG Hypertriglyceridemia | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.130.json | SNOMED CT Gestational Diabetes | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.131.json | ICD10 CM Gestational Diabetes | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.132.json | AHA GWTG Gestational Diabetes | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.133.json | SNOMED CT Hyperglycemia | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.134.json | ICD10 CM Hyperglycemia | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.135.json | AHA GWTG Hyperglycemia | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.136.json | SNOMED CT Nonobstructive CAD | active | 2024-12 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.137.json | ICD10 CM Nonobstructive Coronary Artery Disease | active | 2024-12 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.138.json | AHA GWTG Nonobstructive coronary artery disease | active | 2024-11 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.139.json | AHA GWTG Anti Obesity Pharmacotherapy | active | 2024-12 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.15.json | Non Tobacco Smoking Product User | active | 2024-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.16.json | Antihypertensive Fixed Dose Combination Medications | active | 2024-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.2.json | PCSK9 Inhibitors | active | 2023-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.20.json | CCB and Thiazide and Thiazide Like Diuretics | active | 2021-01 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.21.json | Referral to cardiac rehab | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.22.json | Cardiac Rehabilitation | active | 2021-04 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.25.json | 2 Hour Blood Glucose Test | active | 2022-07 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.26.json | NYHA Functional Classification | active | 2022-07 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.27.json | ARNI Therapy | active | 2022-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.29.json | MRA Therapy | active | 2022-07 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.3.json | Cholesterol non HDL Laboratory Test | active | 2021-04 | us | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.30.json | SGLT2 Inhibitors | active | 2024-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.31.json | Heart Transplant | active | 2022-02 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.32.json | Heart Transplant | active | 2022-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.33.json | Heart Transplant | active | 2022-02 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.34.json | Allergy to MRA Therapy | active | 2024-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.35.json | Aspirin or Clopidogrel | active | 2024-02 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.39.json | Cardiac Rehabilitation | active | 2024-01 | us | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.4.json | Hypothyroidism | active | 2021-04 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.40.json | Cardiac Rehabilitation | active | 2022-07 | us | hl7 | vsac |